Skip to content

Analysis of free fatty acids in plasma for the prognosis of cardiovascular events after acute myocardial infarction

Analysis of free fatty acids in plasma for the prognosis of cardiovascular events after acute myocardial infarction

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048731
Enrollment
Unknown
Registered
2021-07-14
Start date
2020-01-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ST-elevation Myocardial Infarction

Interventions

Case series:No interventions were used in this study

Sponsors

China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with acute ST-segment elevation myocardial infarction will be admitted according to the diagnostic criteria recommended in 2017 by the European Society of Cardiology (ESC) guidelines for ST-segment elevation myocardial infarction. The criteria include: A cardiac biomarker, troponin T, has exceeded the 99th percentile of the upper limit of the reference value at least once and has at least one of the following evidence of myocardial ischemia. 1. Clinical symptoms of myocardial ischemia; 2. The electrocardiogram showed new myocardial ischemia changes and new ST-segment elevation changes of the left bundle branch block. 3. Pathological Q wave appeared in ECG.

Exclusion criteria

Exclusion criteria: (1) Refusal to participate in the study; (2) Refusal to cooperate with the collection of information, or unwilling to follow up; (3) Age over 90 years old; (4) Thyroid dysfunction (thyrotropin 1.5 times the upper limit of the normal value, free thyroxine T4 level is outside the normal range); (5) Severe renal insufficiency (estimated glomerular rate filter 3 times the normal value); (7) Transplant of any major organ; (8) Pregnancy or lactation; (9) Suffering from mental illness; the presence of any infectious or systemic inflammatory disease; (10) Hematological disease; (11) Tumor; (12) Metabolic disease.

Design outcomes

Primary

MeasureTime frame
All-cause Death;heart failure;coronary artery revascularization;

Secondary

MeasureTime frame
Non-fatal myocardial infarction;non-fatal stroke;malignant arrhythmia;unstable angina pectoris hospitalization;

Countries

China

Contacts

Public ContactPing Yang

China-Japan Union Hospital of Jilin University

pyang@jlu.edu.cn+86 13944111519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026